Frank Zerbib
Impact in
- Gastroenterology top 2%
- Celiac Disease Research and Management
- Genetics top 2%
- Inflammatory Bowel Disease
Papers in
- Genetics 17
- Inflammatory Bowel Disease 17
-
- Gastroesophageal reflux and treatments 3
- Co-authors
- Éric Rullier (3 shared papers)David Laharie (13 shared papers)Michel Caudry (1 shared paper)Jean Saric (1 shared paper)Michel Amouretti (3 shared papers)Françis Mégraud (5 shared papers)Victor de Lédinghen (2 shared papers)Paul‐Antoine Lehur (1 shared paper)
In The Last Decade
Frank Zerbib
38 papers receiving 2.5k citations
Frank Zerbib's Hit Papers
Peers
Comparison fields: 5 of 82
- Gastroenterology 250
- Genetics 1.3k
- Epidemiology 706
- Surgery 833
- Hepatology 79
Countries citing papers authored by Frank Zerbib
This map shows the geographic impact of Frank Zerbib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Zerbib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Zerbib more than expected).
Fields of papers citing papers by Frank Zerbib
This network shows the impact of papers produced by Frank Zerbib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Zerbib. The network helps show where Frank Zerbib may publish in the future.
Co-authors
The 25 scholars most cited alongside Frank Zerbib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial Hit paper breakdown → | 2012 | 512 |
| 2 | Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease Hit paper breakdown → | 2017 | 383 |
| 3 | 2016 | 266 | |
| 4 | 2001 | 176 | |
| 5 | 2017 | 137 | |
| 6 | 2014 | 134 | |
| 7 | 2013 | 102 | |
| 8 | 2017 | 90 | |
| 9 | 2004 | 82 | |
| 10 | 2006 | 80 | |
| 11 | 2011 | 77 | |
| 12 | 2016 | 62 | |
| 13 | 2005 | 50 | |
| 14 | 2015 | 47 | |
| 15 | 2010 | 43 | |
| 16 | 2005 | 41 | |
| 17 | 2000 | 34 | |
| 18 | 2006 | 28 | |
| 19 | 2005 | 24 | |
| 20 | 2011 | 23 |
About Frank Zerbib
Frank Zerbib is a scholar working on Genetics, Gastroenterology, Surgery, Epidemiology and Hepatology, having authored 41 papers that have together received 2.5k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (17 papers), Helicobacter pylori-related gastroenterology studies (6 papers), Gastroesophageal reflux and treatments (3 papers), Gallbladder and Bile Duct Disorders (2 papers), Inflammatory mediators and NSAID effects (2 papers), Liver Diseases and Immunity (2 papers), Microscopic Colitis (2 papers) and Eosinophilic Esophagitis (2 papers). The work is most often cited by research in Gastroenterology (250 citations), Genetics (1.3k citations), Epidemiology (706 citations), Surgery (833 citations) and Hepatology (79 citations). Frank Zerbib has collaborated with scholars based in France, Canada and Spain. Frequent co-authors include Éric Rullier, David Laharie, Michel Caudry, Jean Saric, Michel Amouretti, Françis Mégraud, Victor de Lédinghen, Paul‐Antoine Lehur, Alexia Marrel and H Lamouliatte. Their work appears in journals such as Gastroenterology, Digestive and Liver Disease, Alimentary Pharmacology & Therapeutics, Inflammatory Bowel Diseases and Clinical Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.